Corporate News
Vera Therapeutics (VERA) traded up 3.79 % during the 24‑hour period ending at 05:23 AM Central Europe on Friday, 23 November. A single share of Vera Therapeutics is currently priced at approximately USD 29.05 on major exchanges.
Key metrics
| Item | Value |
|---|---|
| Shares outstanding | 72.2 million |
| Market capitalisation | USD 2.2 billion |
| Volume traded in last 24 h | USD 65 million |
| 200‑day simple moving average | USD 37.59 |
| 52‑week high | USD 56.05 (24 Dec 2025) |
| 52‑week low | USD 23.05 (6 Nov 2025) |
Since the end of the previous month, Vera Therapeutics shares have declined 13.95 %.
Recent performance of related stocks
| Company | Ticker | 24‑hr change | Current price | Market cap | P/E (where available) |
|---|---|---|---|---|---|
| Hanesbrands | HN9.F | 0 % | EUR 5.66 | EUR 2.3 billion | 5.65 |
| Beam Therapeutics | BEAM | –0.36 % | USD 24.56 | USD 2.6 billion | — |
| Transmedics | TMDX | –3.14 % | USD 72.06 | USD 2.6 billion | 18.47 |
| Mbx Biosciences | MBX | +0.8 % | USD 50.46 | USD 2.6 billion | — |
| Neogen | NEOG | +0.6 % | USD 11.98 | USD 2.6 billion | — |
Company overview
Vera Therapeutics, Inc. is a clinical‑stage biotechnology company headquartered in South San Francisco, United States. The company focuses on developing and commercializing therapies for patients with serious immunological diseases. Vera Therapeutics operates globally and trades on the NASDAQ stock exchange. Its official website is www.veratx.com .
